A Billion-Scale Dataset for Proteomics AI - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Billion-Scale Dataset for Proteomics AI

  • October 22, 2026

  • 3 min

Share

Objective:

To create a standardized, large-scale mass spectrometry dataset for developing and evaluating artificial intelligence models in proteomics.

Approach:
  • Dataset assembly: Researchers combined 648 projects from PRIDE and iProX, covering 27,643 LC–MS/MS runs, more than 10 high-resolution instrument platforms, and 35 species.
  • Reanalysis and format: They reanalyzed spectra with FragPipe and Sage, removed duplicate identifications, and developed the Mass Spectrometry DDA Tensor (MSDT) format to store spectra, identifications, metadata, and search results.
  • Model evaluation: The team trained XuanjiNovo on 100 million peptide-spectrum matches and benchmarked it against five other de novo peptide-sequencing models across 15 species.
Key Findings:
  • MassNet contains 1.54 billion tandem mass spectra and 548 million peptide-spectrum matches, representing 2.54 million unique peptides and 133,422 proteins.
  • MSDT files were approximately 82% smaller than the combined spectral and search-result files used to create them.
  • In the reported human benchmark, XuanjiNovo peptide recall was 0.45 versus 0.32 for the next-best model; for mouse, recall was 0.68 versus 0.60.
  • Increasing training data from 30 million to 100 million peptide-spectrum matches improved accuracy and performance across species.
  • Predicted and observed retention times correlated at 0.98. The experimental rescoring model identified fewer matches than established FragPipe and Sage workflows.
Interpretation:

MassNet provides a standardized resource for training and comparing proteomics AI models. The study did not evaluate clinical diagnostic performance.

Limitations:
  • The dataset includes spectra confidently identified by FragPipe or Sage, potentially introducing search-related bias and excluding unidentified spectra.
  • Coverage of protein modifications is limited; phosphorylation, glycosylation, ubiquitination, and other modifications were not systematically included.
  • Performance varied across datasets and instrument platforms, and some older-instrument data required additional model training.
  • Human and mouse samples contributed most of the data.
Conclusion:

MassNet is available through PRIDE under accession PXD071590; code, documentation, and trained XuanjiNovo models are also publicly available.

Sources:

Original Source(s)

Related Content